The Data
400+ acquisitions. Every field that matters.
Acquirer, sector, stage, product type, regulatory pathway, device class, rationale code, ownership, upfront, earnout, and deal structure — structured, enriched, and filterable.
Transaction Database
Comprehensive deal history with advanced filtering
| Acquirer | Company Acquired | Sector | Stage | Product Type | Upfront ($M) | Earnout ($M) | Total ($M) | Earnout Structure | Year |
|---|---|---|---|---|---|---|---|---|---|
| Johnson & Johnson | Abiomed | Cardiovascular | Post Commercialization | Therapeutic | $16,600M | $1,619M | $18,219M | Combined | 2022 |
Strategic Context Detailed Sector Cardiovascular-Cardiac Support Rationale Code Expand Existing Product Line Ownership Public Co. Regulatory / Product Profile Regulatory Pathway IDE Device Class Class III Product Code KZE | |||||||||
| Boston Scientific Corporation | Bolt Medical | Cardiovascular | IDE Pivotal Trial Start | 510K Production Ready | Therapeutic | $443M | $221M | $664M | Regulatory | 2025 |
| Stryker Corporation | Mobius Imaging & Cardan Robotics | Surgical | Post Commercialization | Therapeutic | $370M | $130M | $500M | Combined | 2019 |
| Medtronic | Affera Inc | Cardiovascular | IDE Pivotal Trial Start | 510K Production Ready | Surgical | $750M | $250M | $1,000M | Combined | 2022 |
Industry Insights
Market-wide acquisition intelligence across 400+ MedTech deals. Filter by sector, stage, product type, ownership, regulatory pathway, device class, rationale, and earnout structure — then save and share views across your team.
Acquisition Size vs Stage Benchmarks
See where value clears at each development stage — IQR bands, stage averages, medians, and your target valuation plotted against real comparable transactions.
Sector Attractiveness & Deal Momentum
Bubble chart of total deal value vs activity by sector. Stacked annual deal value bar with count overlay — spot where momentum is building or fading.
Stage × Rationale Heatmap
See where deals cluster by stage and acquisition rationale. Identify which combinations attract the most buyer activity and the highest deal density versus those that get punished.
Transaction Database
Filter 400+ acquisitions by acquirer, sector, stage, product type, rationale, ownership, regulatory pathway, device class, and earnout structure. Save views.
Earnout Structure Analysis
Deal Structure Split and Earnout Deal Value Split — understand how often earnouts appear, what share of purchase price they represent, and when buyers require them.
Top Acquirer Activity
Stacked bar of deal value by acquirer and sector. See who the most active buyers are, what sectors they focus on, and how their acquisition pace has shifted.
User Insights
Fill in your sector, stage, product type, ownership, regulatory pathway, and target valuation — and every output filters to your situation. Your Readiness Score and profile history update as your company evolves.
Acquisition Readiness Score
Composite score (0–100) based on your profile, stage fit, and structural signals. Tracks over time as you edit your profile — with delta and biggest-lift attribution.
Strategic Acquirer Landscape
Ranked acquirer cards scored by fit, with relevant M&A transactions, Scores High signals, and Would Hesitate signals — so you know who to call and how to frame it.
Comparable Exit Benchmarking
Your target valuation plotted against 25 comparable exits — IQR band, min–p90 range, named exits labeled, and a clearing probability statement at your ask.
Selected Comparable Transactions
Proximity-scored table of your most comparable exits with full deal detail — upfront, earnout, structure, regulatory pathway, device class, product code. Export to CSV.
Historical Exit Path Analysis
Most Likely, Alternative, and Less Common exit pathways — each showing stage, rationale, product type, median exit value, IQR, typical buyers, and earnout likelihood.
Target Acquirer Fit Table
Ranked table of your selected acquirers with primary sector, device portfolio, rationale, deal structure, and median amount paid — with a notes column for annotations.
VC Insights
Private financing intelligence for MedTech companies seeking institutional funding. Score investor fit, model your valuation across rounds, and benchmark your ask against 450 real Form D filings — whether you're raising now or planning ahead.
Investor Landscape
Ranked investor cards scored by fit, activity, check size consistency, and sweet spot stage alignment — built from 450 SEC EDGAR Form D filings (2010–2025).
Valuation Calculator
Input your funding rounds, multiples, and ownership to compute an estimated valuation range. Inputs are stored and tracked over time as your raise progresses.
Revenue Multiple Calculator
DCF model projecting enterprise value at each milestone year — bear, base, and bull scenarios, discounted by risk-free rate and stage survival probability.
Capital by Stage & Use of Proceeds
See how private capital distributes across development stages and what investors are actually funding — Commercialization, Clinical Development, R&D, or Expansion.
VC Funding Database
450 MedTech financing rounds with full detail: lead investor, co-investors, post-money valuation, cumulative raised, ownership post-round, and use of proceeds.
Round Benchmarking
Benchmark your round size, check size, and stage against comparable financings. See where your ask sits relative to what investors have actually deployed.
Acquisition Defense
Preempt buyer objections. Quantify premium burden. Stress-test your negotiation posture. The Acquisition Defense page reads like an investment analyst brief — built to be taken into the room, not filed away.
Valuation Defense Burden
Historical clearing frequency, percentile rank, and conditions where your premium has cleared — with a Low / Moderate / High / Elevated defense burden label assigned.
Buyer Objection Risk Assessment
Top buyer objections ranked by severity — each with its score, trigger, pattern, defense burden label, room guidance, and historical buyer anchor range.
Acquirer-Specific Attack Surface
Per-buyer cards: clear rate at your target, expected attack vectors, what earns a higher offer, and a historical deal range strip chart for each likely acquirer.
Pre-Process Negotiation Posture
Four-quadrant strategic brief: your opening position, primary exposure, the move that changes your outcome, and a Process Timing Signal with Headwind or Tailwind label.
Comparable Exit Conditions
Profile of exits that cleared at or above your target — stage, product type, rationale, ownership, and deal structure they shared. Understand the clearing cohort.
Valuation Range Benchmarking
Your target vs median, 75th percentile, and 90th percentile of comparable exits — premium required vs median stated as a percentage, with your percentile rank explicit.